Canada · Health Canada Drug Product Database

FORMULA GLY

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
19930
DIN
01975951
Form
Tablet
Company as listed by source
SEROYAL INTERNATIONAL INC.
Source status
Cancelled Post Market (2009-07-06)
Source last updated
2025-03-22

Source-listed ingredients

  • RETINOL PALMITATE — 833.33 UNIT
  • BETA-CAROTENE — 833.33 UNIT
  • VITAMIN B1 — 16.67 MG
  • VITAMIN B2 — 16.67 MG
  • NICOTINAMIDE — 135 MG
  • BIOTIN — 16.67 MCG
  • CALCIUM D-PANTOTHENATE — 83.33 MG
  • PYRIDOXINE HYDROCHLORIDE — 25 MG
  • VITAMIN B12 — 33.33 MCG
  • FOLIC ACID — .067 MG
  • ASCORBIC ACID — 83.33 MG
  • CHOLINE BITARTRATE — 16.67 MG
  • INOSITOL — 4.17 MG
  • DL-METHIONINE — 16.67 MG
  • MAGNESIUM (MAGNESIUM PROTEINATE) — 8.33 MG
  • POTASSIUM (POTASSIUM PROTEINATE) — 9.17 MG
  • ZINC (ZINC PROTEINATE) — 2.5 MG
  • MANGANESE (MANGANESE PROTEINATE) — 3.33 MG
  • CHROMIUM (CHROMIUM PROTEINATE) — 37.5 MCG
  • SELENIUM (SELENIUM PROTEINATE) — 25 MCG

These values do not establish equivalence or a dose recommendation.

Packages

  • 180 Tablets

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →